{"entity":{"type":"insider","cik":"0001534425","url":"/insider/0001534425","json_url":"/insider/0001534425.json","name":"Pillar Pharmaceuticals I LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":66,"n_filings":13,"first":"2013-05-17","last":"2020-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Pillar Pharmaceuticals I LP","source":"filing","n_filings":13,"first_seen":"2013-05-17","last_seen":"2020-02-26"}],"transactions":[{"id":2592244,"accession":"0000899243-20-005917","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17250.0,"shares_display":"17,250","price_per_share":1.7645,"price_display":"1.76","price_state":"stated","total_value":30437.625,"total_display":"30,437.62","total_whole":"30,438","shares_owned_after":3254442.0,"shares_owned_after_display":"3,254,442","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-29","filed_date":"2020-02-26","scope":"insider"},{"id":2592238,"accession":"0000899243-20-005917","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12532.0,"shares_display":"12,532","price_per_share":1.762,"price_display":"1.76","price_state":"stated","total_value":22081.384,"total_display":"22,081.38","total_whole":"22,081","shares_owned_after":3271692.0,"shares_owned_after_display":"3,271,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-28","filed_date":"2020-02-26","scope":"insider"},{"id":2592235,"accession":"0000899243-20-005917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":26550.0,"total_display":"26,550.00","total_whole":"26,550","shares_owned_after":3284224.0,"shares_owned_after_display":"3,284,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-02-26","scope":"insider"},{"id":7909824,"accession":"0000899243-19-027012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":21960.0,"total_display":"21,960.00","total_whole":"21,960","shares_owned_after":3299224.0,"shares_owned_after_display":"3,299,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-08","scope":"insider"},{"id":7909821,"accession":"0000899243-19-027012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":3308224.0,"shares_owned_after_display":"3,308,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-07","filed_date":"2019-11-08","scope":"insider"},{"id":7909818,"accession":"0000899243-19-027012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":2.4956,"price_display":"2.50","price_state":"stated","total_value":249560.0,"total_display":"249,560.00","total_whole":"249,560","shares_owned_after":3318224.0,"shares_owned_after_display":"3,318,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-06","filed_date":"2019-11-08","scope":"insider"},{"id":6343903,"accession":"0000899243-18-022726","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-18-022726","line_url":"/filing/0000899243-18-022726","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":6.298963636363636,"price_display":"6.30","price_state":"stated","total_value":346443.0,"total_display":"346,443.00","total_whole":"346,443","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-09","filed_date":"2018-08-17","scope":"insider","n_lines":3},{"id":6343894,"accession":"0000899243-18-022726","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-18-022726","line_url":"/filing/0000899243-18-022726","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78107.0,"shares_display":"78,107","price_per_share":5.9079102730869195,"price_display":"5.91","price_state":"stated","total_value":461449.1477,"total_display":"461,449.15","total_whole":"461,449","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-17","scope":"insider","n_lines":3},{"id":6343885,"accession":"0000899243-18-022726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-022726","line_url":"/filing/0000899243-18-022726","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166893.0,"shares_display":"166,893","price_per_share":5.583311121497007,"price_display":"5.58","price_state":"stated","total_value":931815.543,"total_display":"931,815.54","total_whole":"931,816","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-07","filed_date":"2018-08-17","scope":"insider","n_lines":2},{"id":4138397,"accession":"0000899243-17-011717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-011717","line_url":"/filing/0000899243-17-011717","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals I LP; Pillar Invest Corp; ZEIN YOUSSEF EL; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals I LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450815.0,"shares_display":"450,815","price_per_share":2.2591,"price_display":"2.26","price_state":"stated","total_value":1018436.1665,"total_display":"1,018,436.17","total_whole":"1,018,436","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-01","filed_date":"2017-05-03","scope":"insider","n_lines":2},{"id":5236953,"accession":"0000899243-17-010925","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-010925","line_url":"/filing/0000899243-17-010925#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals I LP; Pillar Invest Corp; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals I LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":890593.0,"shares_display":"890,593","price_per_share":2.2883,"price_display":"2.29","price_state":"stated","total_value":2037943.9619,"total_display":"2,037,943.96","total_whole":"2,037,944","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-25","filed_date":"2017-04-26","scope":"insider"},{"id":5236948,"accession":"0000899243-17-010925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-010925","line_url":"/filing/0000899243-17-010925#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals I LP; Pillar Invest Corp; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals I LP","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":437829.0,"shares_display":"437,829","price_per_share":2.2887,"price_display":"2.29","price_state":"stated","total_value":1002059.2323,"total_display":"1,002,059.23","total_whole":"1,002,059","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-04-24","filed_date":"2017-04-26","scope":"insider"},{"id":8170590,"accession":"0000899243-15-010065","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-15-010065","line_url":"/filing/0000899243-15-010065#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77587.0,"shares_display":"77,587","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider"},{"id":8170586,"accession":"0000899243-15-010065","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-15-010065","line_url":"/filing/0000899243-15-010065#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77586.0,"shares_display":"77,586","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider"},{"id":8170583,"accession":"0000899243-15-010065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-010065","line_url":"/filing/0000899243-15-010065#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77586.0,"shares_display":"77,586","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2015-12-17","scope":"insider"},{"id":8268214,"accession":"0000899243-15-009800","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-9","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2015-12-14","scope":"insider"},{"id":8268210,"accession":"0000899243-15-009800","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-8","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2015-12-14","scope":"insider"},{"id":8268203,"accession":"0000899243-15-009800","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-7","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2015-12-14","scope":"insider"},{"id":8268199,"accession":"0000899243-15-009800","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-6","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":770155.0,"shares_display":"770,155","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-14","scope":"insider"},{"id":8268197,"accession":"0000899243-15-009800","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-5","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":676536.0,"shares_display":"676,536","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-14","scope":"insider"},{"id":8268193,"accession":"0000899243-15-009800","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-4","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":676535.0,"shares_display":"676,535","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-14","scope":"insider"},{"id":8268189,"accession":"0000899243-15-009800","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":359847.0,"shares_display":"359,847","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-11","filed_date":"2015-12-14","scope":"insider"},{"id":8268186,"accession":"0000899243-15-009800","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25591.0,"shares_display":"25,591","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-14","scope":"insider"},{"id":8268181,"accession":"0000899243-15-009800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-009800","line_url":"/filing/0000899243-15-009800#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals IV, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25590.0,"shares_display":"25,590","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-10","filed_date":"2015-12-14","scope":"insider"},{"id":6653740,"accession":"0001209191-14-075984","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-13","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":339018.0,"shares_display":"339,018","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-16","scope":"insider"},{"id":6653736,"accession":"0001209191-14-075984","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-12","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93230.0,"shares_display":"93,230","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-16","scope":"insider"},{"id":6653733,"accession":"0001209191-14-075984","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-11","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67804.0,"shares_display":"67,804","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-16","scope":"insider"},{"id":6653730,"accession":"0001209191-14-075984","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-10","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50853.0,"shares_display":"50,853","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-16","scope":"insider"},{"id":6653726,"accession":"0001209191-14-075984","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-9","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178462.0,"shares_display":"178,462","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6653720,"accession":"0001209191-14-075984","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-8","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49077.0,"shares_display":"49,077","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6653716,"accession":"0001209191-14-075984","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-7","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35692.0,"shares_display":"35,692","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6653714,"accession":"0001209191-14-075984","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-6","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26769.0,"shares_display":"26,769","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-16","scope":"insider"},{"id":6653712,"accession":"0001209191-14-075984","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-5","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160521.0,"shares_display":"160,521","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-16","scope":"insider"},{"id":6653709,"accession":"0001209191-14-075984","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-4","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44143.0,"shares_display":"44,143","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-16","scope":"insider"},{"id":6653706,"accession":"0001209191-14-075984","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32104.0,"shares_display":"32,104","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-16","scope":"insider"},{"id":6653701,"accession":"0001209191-14-075984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-075984","line_url":"/filing/0001209191-14-075984#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals III, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Pharmaceuticals IV, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24078.0,"shares_display":"24,078","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-12","filed_date":"2014-12-16","scope":"insider"},{"id":6389160,"accession":"0001209191-14-074765","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-14-074765","line_url":"/filing/0001209191-14-074765#line-15","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals I LP; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":438836.0,"shares_display":"438,836","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-11","scope":"insider"},{"id":6389158,"accession":"0001209191-14-074765","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-14-074765","line_url":"/filing/0001209191-14-074765#line-14","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals I LP; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120680.0,"shares_display":"120,680","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-11","scope":"insider"},{"id":6389156,"accession":"0001209191-14-074765","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-14-074765","line_url":"/filing/0001209191-14-074765#line-13","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals I LP; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87767.0,"shares_display":"87,767","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-11","scope":"insider"},{"id":6389153,"accession":"0001209191-14-074765","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-14-074765","line_url":"/filing/0001209191-14-074765#line-12","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals I LP; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65825.0,"shares_display":"65,825","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-11","filed_date":"2014-12-11","scope":"insider"},{"id":6389146,"accession":"0001209191-14-074765","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-14-074765","line_url":"/filing/0001209191-14-074765#line-10","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals I LP; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":216028.0,"shares_display":"216,028","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-11","scope":"insider"},{"id":6389143,"accession":"0001209191-14-074765","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-14-074765","line_url":"/filing/0001209191-14-074765#line-9","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals I LP; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59408.0,"shares_display":"59,408","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-11","scope":"insider"},{"id":6389140,"accession":"0001209191-14-074765","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-14-074765","line_url":"/filing/0001209191-14-074765#line-8","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals I LP; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43206.0,"shares_display":"43,206","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-11","scope":"insider"},{"id":6389137,"accession":"0001209191-14-074765","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-074765","line_url":"/filing/0001209191-14-074765#line-7","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals II, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals III, L.P.; Pillar Invest Corp; Pillar Pharmaceuticals I LP; ZEIN YOUSSEF EL","owner_display_name":"Pillar Pharmaceuticals II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32404.0,"shares_display":"32,404","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-10","filed_date":"2014-12-11","scope":"insider"}],"collapsed":true,"next_cursor":"2014-12-10|6389137","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"IDERA PHARMACEUTICALS, INC.","url":"/issuer/0000861838","role":"Director, Ten percent owner","n_filings":13,"first_seen":"2013-05-17","last_seen":"2020-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001534425","retrieved_at":"2026-08-23T00:55:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}